Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-09-21

Clinical Trial Update: Oral Rivaroxaban in Children With Venous Thrombosis [Phase 2]

View source ↗

Summary

Phase 2 trial update on oral rivaroxaban in children with venous thrombosis; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Bayer | Conditions: Venous Thrombosis | Phase 2 | Status: COMPLETED | Results posted: 2017-09-21